SAT-462 First-in-human single and multiple ascending dose study of AZD2389, a potent inhibitor of fibroblast activation protein, in healthy participants to evaluate safety, tolerability, pharmacokinetics and target engagement
耐受性
药代动力学
药理学
医学
化学
不利影响
作者
Vian Azzu,Samuel J. Daniels,Mathias Liljeblad,Tiffany Schärer,Mohammad Niazi,Alfredo G. Casanova,David Janzén,Dev P. Arya,Victoria Parker,Karin Björhall,Anna Bogstedt,Tasso Miliotis,Pavlo Garkaviy,Jelena Saillard,Mohammad Hossein Karimi,Armando Flor
PDF的下载单位、IP信息已删除
Rondab
迷人的天抒
孙孙
轻松的惜芹
七慕凉
jyy
pcr163
风雨中飘摇
Alice
GingerF
YamDaamCaa
bxxxxx
SYLH
eric888
Hayat
vin
贰鸟
xixi
Lily
半城微凉
皖公网安备34019202002308
